Stocks · Healthcare · Biotechnology

Septerna Inc SEPN

$37.71 -0.89% Close, Oct 2, 2026 · NASDAQ · Market cap $1.70B

Strong growthHigh qualityStrong trendHigh risk

Next earnings report: Nov 9, 2026

Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.

Three things to know

  1. Revenue over the last four quarters was $98.9M, up 13520.1% from a year earlier, accelerating from 7295.6% a quarter earlier.
  2. Operating margin widened to -44.0% from -14071.1% a year earlier.
  3. Over the past year the stock returned +98.5%, ahead of the S&P 500 by 83.4 percentage points.

PromtFinance scores

Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.

Growth100Exceptional

How fast revenue, earnings and cash flow are growing.

  • Revenue growth (TTM, YoY)Top 1%
  • Revenue growth accelerationTop 1%
Quality93Exceptional

Returns on capital, margins, earnings quality and balance-sheet strength.

  • Return on invested capitalTop 42%
  • Gross marginTop 6%
  • Operating marginBottom 36%
  • Accruals (lower is better)Top 11%
Value62Neutral

How cheap the shares are relative to earnings, cash flow and their own history.

  • Earnings yieldTop 33%
  • Free-cash-flow yieldTop 14%
  • EBITDA / enterprise valueTop 44%
  • Sales / enterprise valueBottom 23%
Momentum80Strong

Strength and persistence of the price trend, including versus the S&P 500.

  • 12-month return excluding last monthTop 18%
  • 6-month returnTop 19%
  • 1-year return vs S&P 500Top 15%
  • Distance from 52-week highTop 41%
  • Trend checklist (0–4)Top 39%
Revisions62Neutral

Earnings surprises and analyst sentiment (estimate-revision history is being collected).

  • Average EPS surprise, last 4 quartersBottom 25%
  • Consecutive EPS beatsTop 35%
  • Share of analysts rating BuyTop 10%
  • Upside to consensus price targetBottom 37%
Stability16Very weak

Low volatility, shallow drawdowns, low market sensitivity and modest leverage.

  • Volatility, 60 days (lower is better)Bottom 33%
  • Maximum drawdown, 3 yearsBottom 29%
  • Beta vs S&P 500 (lower is better)Bottom 11%

What changed

Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).

MeasureBeforeNow
Revenue growth (YoY)7295.6%13520.1%↑
Gross margin100.0%99.6%↓
Operating margin-14071.1%-44.0%↑
FCF margin-11436.9%106.3%↑

Fundamental momentum

MeasureNow (TTM)Year / quarter beforeSector rank
Revenue growth (TTM, YoY)13520.1%7295.6%↑Top 1%
Gross margin99.6%100.0%↓Top 6%
Operating margin-44.0%-14071.1%↑Bottom 36%
Net margin-24.5%-12053.0%↑—
Free-cash-flow margin106.3%-11436.9%↑—
Return on invested capital-8.9%—Top 42%

Quality of earnings and balance sheet

Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
-23.0%
Stock-based compensation / revenueA cost to shareholders through dilution.
16.5%
Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
-12999.0 pp
Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
Net cash

Shareholder returns

Dividend yield (dividends paid, TTM)
0.00%
Net buyback yield (TTM)
-1.08%
Shareholder yield
-1.08%
Share count change, 1 year
+2.0%

Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.

Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).

Earnings and expectations

Earnings momentum

Consecutive EPS beats
2
Beats in the last 8 reports
3 of 8
Average EPS surprise, last 4
-14.3%
Average 2-day reaction, last 8
+0.2%
Positive 20 days after report
6 of 8

Analysts

Consensus price target
$50.40
Target vs current price
+33.7%
Analysts with a rating
9
Share rating Buy or Strong Buy
100%
Consensus rating
Buy

How the stock reacted to recent reports

Report dateEPS surprise2 days5 days20 days60 days
Aug 10, 2026+31.9%+0.1%+14.6%-5.4%—
May 12, 2026+62.7%+5.4%+11.6%+31.6%+67.7%
Mar 9, 2026-4.3%+1.0%-12.6%-13.9%+4.0%
Nov 10, 2025-147.4%-2.2%+25.7%+40.2%+32.0%
Aug 11, 2025-1020.0%-1.7%+0.3%+25.5%+71.5%
May 15, 2025-28.9%-0.4%-10.8%+2.5%+13.1%
Mar 27, 2025+7.2%+2.4%-10.6%+5.2%+71.5%
Nov 21, 2024-912.0%-3.2%+10.1%+4.0%-73.8%

Returns from the close before each report. Past reactions do not determine future ones.

Earnings history

Report dateEPSEstimateSurpriseRevenue
Aug 10, 2026-$0.29-$0.43+31.9%$26.7M
May 12, 2026-$0.19-$0.51+62.7%$26.5M
Mar 9, 2026-$0.24-$0.23-4.3%$24.1M
Nov 10, 2025-$0.09$0.19-147.4%$21.5M
Aug 11, 2025-$0.56-$0.05-1020.0%$119,000
May 15, 2025-$0.49-$0.38-28.9%$219,000
Mar 27, 2025-$0.64-$0.69+7.2%$212,000
Nov 21, 2024-$8.40-$0.83-912.0%$176,000

Valuation in context

MultipleNow5-year median5-year percentileSector rank (cheapness)
EV / Sales16.56×——Bottom 23%
Free-cash-flow yield6.18%——Top 14%
Earnings yield-1.43%——Top 33%

Technical state

Trend checklist

  • ✗ Price above 20-day average
  • ✗ Price above 50-day average
  • ✓ Price above 200-day average
  • ✓ 50-day average above 200-day
  • ✗ MACD histogram positive

Trend quality

Days above the 50-day average
0
Days above the 200-day average
273
50-day average slope (20 days)
+4.3%
200-day average slope (20 days)
+4.2%
Distance from 50-day average
-3.5%
Distance from 200-day average
+22.1%
RSI (14)
45.3
Relative volume
1.13×

Risk and drawdowns

Volatility, 60 days (annualized)
66.1%
Volatility vs own 5-year history
41th percentile · Normal for this stock
Beta vs S&P 500 (2 years, weekly)
2.09
Correlation with S&P 500
0.38
Current drawdown from 1-year high
-21.7%
Maximum drawdown, 3 years
-81.5%

Largest declines in the past six years

From peakTo lowDeclineLengthRecovery
Dec 23, 2024Apr 1, 2025-81.5%66 days164 days (Nov 24, 2025)
Feb 24, 2026Apr 10, 2026-25.2%32 days33 days (May 28, 2026)
Aug 12, 2026Sep 4, 2026-23.7%17 daysNot yet recovered
Dec 19, 2025Jan 30, 2026-21.1%27 days11 days (Feb 17, 2026)
Dec 4, 2024Dec 16, 2024-16.8%8 days5 days (Dec 23, 2024)

Declines of 10% or more from a closing high, measured on daily closes.

Financial statements

Market cap
$1.70B
EPS, diluted (TTM)
-$0.54
Revenue (TTM)
$98.9M
52-week range
$17.55 – $51.10
FY 2023FY 2024FY 2025
Revenue$151,000$1.1M$46.0M
Gross profit$151,000$1.1M$46.0M
Operating income$2.1M-$80.8M-$80.8M
Net income$4.2M-$71.8M-$48.9M
EPS (diluted)$0.03-$1.93-$1.10
Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Revenue$176,000$212,000$219,000$119,000$21.5M$24.1M$26.5M$26.7M
Net income-$20.5M-$20.7M-$21.5M-$24.8M$8.2M-$10.7M-$8.6M-$13.0M
EPS (diluted)-$0.49-$0.64-$0.49-$0.56$0.18-$0.24-$0.19-$0.29
FY 2022FY 2023FY 2024FY 2025
Operating cash flow-$23.3M-$38.7M-$67.5M$110.2M
Capital expenditure-$1.3M-$2.9M-$2.1M-$518,000
Free cash flow-$24.6M-$41.6M-$69.6M$109.7M
Dividends paid$0$0$0$0
Net share buybacks$82,000-$1,000$302.8M$1.7M

Cash outflows are shown as negative numbers.

Cash and short-term investments
$372.3M
Total assets
$566.7M
Total liabilities
$180.0M
Total debt
$22.5M
Net debt
-$62.1M
Shareholders’ equity
$386.7M

As of Jun 30, 2026 (filed Aug 10, 2026).

Short interest

Shares sold short
2,894,002
Days to cover
9.54
Change vs previous report
+6.5%

FINRA short interest, settlement date Sep 15, 2026.